SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 316 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $253,000 | -13.9% | 9,212 | +3.8% | 0.01% | -11.1% |
| Q2 2019 | $294,000 | -5.5% | 8,876 | 0.0% | 0.01% | -10.0% |
| Q1 2019 | $311,000 | +5.4% | 8,876 | 0.0% | 0.01% | -9.1% |
| Q4 2018 | $295,000 | -34.0% | 8,876 | 0.0% | 0.01% | -21.4% |
| Q3 2018 | $447,000 | +3.0% | 8,876 | +22.4% | 0.01% | 0.0% |
| Q2 2018 | $434,000 | +30.7% | 7,252 | 0.0% | 0.01% | +27.3% |
| Q1 2018 | $332,000 | +19.9% | 7,252 | +4.4% | 0.01% | +22.2% |
| Q4 2017 | $277,000 | +26.5% | 6,944 | +26.5% | 0.01% | +12.5% |
| Q3 2017 | $219,000 | +6.8% | 5,488 | +15.3% | 0.01% | 0.0% |
| Q2 2017 | $205,000 | +159.5% | 4,760 | +88.9% | 0.01% | +166.7% |
| Q1 2017 | $79,000 | +38.6% | 2,520 | +11.1% | 0.00% | 0.0% |
| Q4 2016 | $57,000 | – | 2,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |